UPDATE - Global Hunter Securities Initiates Coverage on Western Refining (WNR) with a Neutral; Shares Remain a Levered Play to WTI Discount
Get Alerts WNR Hot Sheet
Price: $36.18 --0%
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Global Hunter Securities initiates coverage on Western Refining (NYSE: WNR) with a Neutral.
Global analyst said, "Western Refining has experienced a windfall year given its position as one of the prime beneficiaries of crude price dislocations in North America. The sustained WTI discount has been a balance sheet transformative event, with the company potentially approaching a net debt free position by the end of 2012 after remaining in financial distress up until the end of 2010. While we expect continued cash generation for Western in the coming quarters amid sustained favorable feedstock differentials, we believe investors may continue to focus more on lower levered companies with more optionality to return cash to shareholders."
To see more ratings changes on WNR, Click Here
Global analyst said, "Western Refining has experienced a windfall year given its position as one of the prime beneficiaries of crude price dislocations in North America. The sustained WTI discount has been a balance sheet transformative event, with the company potentially approaching a net debt free position by the end of 2012 after remaining in financial distress up until the end of 2010. While we expect continued cash generation for Western in the coming quarters amid sustained favorable feedstock differentials, we believe investors may continue to focus more on lower levered companies with more optionality to return cash to shareholders."
To see more ratings changes on WNR, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iran’s president calls for end to war with US
- TD Cowen Assumes Atara Biotherapeutics (ATRA) at Buy
- TD Cowen Assumes Nektar Therapeutics (NKTR) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Crude OilSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share